Physician profile
Fred A Tega
NPI 1043265259
$2,124.43
in general payments reported to CMS, 2019-2025
23 companies · $211 in 2025
The $211 reported for 2025 was more than what 75% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $279 · 2020: $66.61 · 2021: $354 · 2022: $600 · 2023: $195 · 2024: $418 · 2025: $211.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $825.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $824.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cranial Technologies, INC | $522.10 | 2019-2025 | Doc Band |
| Baxter Healthcare | $440.00 | 2022 | |
| Welch Allyn | $220.00 | 2021 | |
| Sanofi-Aventis U.S. LLC | $213.23 | 2024-2025 | |
| Sanofi Pasteur INC. | $102.99 | 2019-2025 | |
| Ironshore Pharmaceuticals INC. | $76.59 | 2019-2023 | Jornay Pm |
| Pfizer INC. | $64.65 | 2024-2025 | |
| Verrica Pharmaceuticals INC. | $59.98 | 2024 | Ycanth |
| Shire North American Group INC | $51.83 | 2019 | |
| Phadia US INC. | $50.48 | 2019-2024 | Immunocap |
| Merck Sharp & Dohme LLC | $41.53 | 2019-2025 | Proquad, Enflonsia, Vaxelis |
| Glaxosmithkline, LLC. | $32.49 | 2019 | |
| Corium, LLC | $31.38 | 2023 | Azstarys |
| Sobi, INC | $30.09 | 2019-2021 | |
| Adlon Therapeutics L.P. | $29.51 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kaleo, INC. | $29.10 | 2019 | |
| Supernus Pharmaceuticals, INC. | $26.64 | 2021-2022 | |
| Lnhc, INC | $26.34 | 2025 | Zelsuvmi |
| Tempus Ai, INC | $18.87 | 2024 | |
| Aytu Biopharma, INC. | $18.23 | 2020 | |
| Biomarin Pharmaceutical INC. | $14.98 | 2025 | Voxzogo 1.2mg |
| Mission Pharmacal Company | $12.48 | 2019 | |
| Neos Therapeutics, LP | $10.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fred Tega listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.